MD1505F1 - Preparation for treatment of rheumatoid affections - Google Patents

Preparation for treatment of rheumatoid affections

Info

Publication number
MD1505F1
MD1505F1 MD990282A MD990282A MD1505F1 MD 1505 F1 MD1505 F1 MD 1505F1 MD 990282 A MD990282 A MD 990282A MD 990282 A MD990282 A MD 990282A MD 1505 F1 MD1505 F1 MD 1505F1
Authority
MD
Moldova
Prior art keywords
rheumatoid
affections
treatment
preparation
immunoglobulin
Prior art date
Application number
MD990282A
Other languages
Romanian (ro)
Other versions
MD1505G2 (en
Inventor
Ghenadie Mordvinov
Original Assignee
Ghenadie Mordvinov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghenadie Mordvinov filed Critical Ghenadie Mordvinov
Priority to MD99-0282A priority Critical patent/MD1505G2/en
Publication of MD1505F1 publication Critical patent/MD1505F1/en
Publication of MD1505G2 publication Critical patent/MD1505G2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention relates to medicine and is provided for treatment of patients with rheumatoid affections. The preparation for treatment of rheumatoid affections comprises aggregated human G immunoglobulin in the form of a 10% aqueous solution. The result of the invention consists in the inhibition of the rheumatoid factor synthesis. Claims: 2
MD99-0282A 1999-12-17 1999-12-17 Preparation for treatment of rheumatoid affections MD1505G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD99-0282A MD1505G2 (en) 1999-12-17 1999-12-17 Preparation for treatment of rheumatoid affections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD99-0282A MD1505G2 (en) 1999-12-17 1999-12-17 Preparation for treatment of rheumatoid affections

Publications (2)

Publication Number Publication Date
MD1505F1 true MD1505F1 (en) 2000-07-31
MD1505G2 MD1505G2 (en) 2001-01-31

Family

ID=19739503

Family Applications (1)

Application Number Title Priority Date Filing Date
MD99-0282A MD1505G2 (en) 1999-12-17 1999-12-17 Preparation for treatment of rheumatoid affections

Country Status (1)

Country Link
MD (1) MD1505G2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3144G2 (en) * 2006-04-03 2007-04-30 Генадие МОРДВИНОВ Remedy for treating the rheumatic arthritis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1226G2 (en) * 1998-10-06 1999-10-31 Генадие МОРДВИНОВ Preparation for treatment of rheumatoid diseases

Also Published As

Publication number Publication date
MD1505G2 (en) 2001-01-31

Similar Documents

Publication Publication Date Title
DE69528604T2 (en) MEDICINE TREATMENT OF SICK LOW-FLYING AREAS INSIDE THE BODY
HUP0203556A2 (en) Pharmaceutical compositions containing oxcarbazepine and their use
SI1296633T1 (en) Medicinal product package for eradication therapy
DE69721766D1 (en) NEW MEDICAL FORMULATION
DE3684190D1 (en) USE OF TETRAHYDROBIOPTERINES FOR PRODUCING A MEDICINE FOR TREATING CHILDREN'S AUTISM.
ATE326867T1 (en) COMPOSITION CONTAINING FREE AMINO ACID
ATE141792T1 (en) USE OF CARBAMAZEPINE AND OXCARBAZEPINE FOR THE TREATMENT OF PARKINSON'S AND PARKINSON'S SYNDROME
MX9501848A (en) New polyenic compounds, pharmaceutical and cosmetic compositions containing them and their uses.
GR3035402T3 (en) Use of incense in the treatment of alzheimer's disease
ATE219670T1 (en) USE OF ARACHIDONIC ACID AND/OR DOCOHEXAENE ACID IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DYSPRAXIA
MX9708800A (en) Bicyclic-aromatic compounds.
MY164077A (en) Compositions and uses of et743 for treating cancer
MX9708803A (en) Diaromatic propynyl or dienyl compounds.
KR950031063A (en) Using pravastatin to slow the progression of coronary atherosclerosis
HK1055080A1 (en) Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
BR0009380A (en) Improved cancer treatment with temozozomide
MD1505F1 (en) Preparation for treatment of rheumatoid affections
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
KR100271087B1 (en) Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
DE69315162T2 (en) Use of L-carnitine and acyl-L-carnitine for the treatment of patients suffering from AIDS-related syndromes and of asymptomatic HIV-seropositive patients
ATE204476T1 (en) USE OF 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZI E TO PRODUCE A MEDICATION FOR THE TREATMENT OF CERTAIN PAIN AND EDEMA
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
MD1226F1 (en) Preparation for treatment of rheumatoid diseases
FR2658190B1 (en) HYDROQUINONE AMINO ACID ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM.
UA41652A (en) METHOD OF TREATMENT OF PATIENTS WITH HYPERTENSION

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees